63 00148-5 20. Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142(12):3728-3736. doi:10.1093/brain/awz333 21. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res. 2003;54(4):345-352. doi:10.1016/S0022-3999(02)00392-6 22. Hendriks C, Drent M, Elfferich M, De Vries J. The Fatigue Assessment Scale: Quality and availability in sarcoidosis and other diseases. Curr Opin Pulm Med. 2018;24(5):495-503. doi:10.1097/MCP.0000000000000496 23. Campbell WI, Lewis S. Visual analogue measurement of pain. Ulster Med J. 1990;59(2):149-154. 24. Rago R, Forfori F, Materazzi G, et al. Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. Clin J Pain. 2012;28(5):382-386. doi:10.1097/AJP.0b013e3182326495 25. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-132. doi:10.1016/S1389-9457(02)00258-7 26. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1-16. doi:10.1111/j.2044-8260.1982.tb01421.x 27. Ponds R, Boxtel M Van, Jolles J. De “Cognitive Failure Questionnaire” Als Maat Voor Subjectief Cognitief Functioneren. Tijdschr voor Neuropsychol. 2006;2(1):37-45. 28. Singha A, Kirkland M, Drake W, Crouser ED. The influence of age and sex in sarcoidosis. Curr Opin Pulm Med. 2022;28(4):307-313. doi:10.1097/MCP.0000000000000882 29. Johnson SA, Shouman K, Shelly S, et al. Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability. Neurology. 2021;97(22):E2236-E2247. doi:10.1212/WNL.0000000000012894 30. De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol. 2004;9(Pt 3):279-291. doi:10.1348/1359107041557048 31. Silber MH, Buchfuhrer MJ, Earley CJ, et al. The Management of Restless Legs Syndrome: An Updated Algorithm. Mayo Clin Proc. 2021;96(7):1921-1937. doi:10.1016/j.mayocp.2020.12.026 32. Drent M MRLADVJ. Association between physical functions and quality of life in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 2014;31(2):117-128. 33. Carrigan N, Barkus E. A systematic review of cognitive failures in daily life: Healthy populations. Neurosci Biobehav Rev. 2016;63:29-42. doi:10.1016/j.neubiorev.2016.01.010 34. Mackie S, Winkelman JW. Restless Legs Syndrome and Psychiatric Disorders. Sleep Med Clin. 2015;10(3):351-357. doi:10.1016/j.jsmc.2015.05.009 35. Guay A, Houle M, O’Shaughnessy J, Descarreaux M. Current Evidence on Diagnostic Criteria, Relevant Outcome Measures, and Efficacy of Nonpharmacologic Therapy in the Management of Restless Legs Syndrome (RLS): A Scoping Review. J Manipulative Physiol Ther. 2020;43(9):930-941. doi:10.1016/j.jmpt.2020.05.004 36. Lower EE, Harman S, Baughman RP. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest. 2008;133(5):11891195. doi:10.1378/chest.07-2952 37. Lower EE, Malhotra A, Surdulescu V, Baughman RP. Armodafinil for sarcoidosis-associated fatigue: A double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2013;45(2):159-169. doi:10.1016/j.jpainsymman.2012.02.016 38. Vis R, van de Garde EMW, Meek B, Korenromp IHE, Grutters JC. Randomised, placebocontrolled trial of dexamethasone for quality of life in pulmonary sarcoidosis. Respir Med. 2020;165. doi:10.1016/j.rmed.2020.105936 39. Kahlmann V, Moor CC, van Helmondt SJ, et al. Online mindfulness-based cognitive therapy for 3 66 3
RkJQdWJsaXNoZXIy MjY0ODMw